{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:27:48Z","timestamp":1788280068830,"version":"build-2803163510"},"reference-count":19,"publisher":"BMJ","issue":"1","funder":[{"name":"Austrian Federal Ministry of Economy, Family and Youth, National Foundation for Research, Technology and Development."}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Background\/aims<\/jats:title><jats:p>To characterise neuroretinal atrophy in retinal vein occlusion (RVO).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included patients with central\/branch RVO (CRVO=196, BRVO=107) who received ranibizumab according to a standardised protocol for 6 months. Retinal atrophy was defined as the presence of an area of retinal thickness (RT) &lt;260\u2009\u00b5m outside the foveal centre. Moreover, the thickness of three distinct retinal layer compartments was computed as follows: (1) retinal nerve fibre layer to ganglion cell layer, (2) inner plexiform layer (IPL) to outer nuclear layer (ONL) and (3) inner segment\/outer segment junction to retinal pigment epithelium. To characterise atrophy further, we assessed perfusion status on fluorescein angiography and best-corrected visual acuity (BCVA), and compared these between eyes with\/without atrophy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>23 patients with CRVO and 11 patients with BRVO demonstrated retinal atrophy, presenting as sharply demarcated retinal thinning confined to a macular quadrant. The mean RT in the atrophic quadrant at month 6 was 249\u00b126\u2009\u00b5m (CRVO) and 244\u00b129\u2009\u00b5m (BRVO). Individual layer analysis revealed pronounced thinning in the IPL to ONL compartment. Change in BCVA at 6 months was similar between the groups (BRVO, +15\u2009vs +18\u2009letters; CRVO, +14\u2009vs +18 letters).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this exploratory analysis, we describe the characteristics of neuroretinal atrophy in RVO eyes with resolved macular oedema after ranibizumab therapy. Our analysis shows significant, predominantly retinal thinning in the IPL to ONL compartment in focal macular areas in 11% of patients with RVO. Eyes with retinal atrophy did not show poorer BCVA outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-311614","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T17:15:36Z","timestamp":1520356536000},"page":"36-42","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Neuroretinal atrophy following resolution of macular oedema in retinal vein occlusion"],"prefix":"10.1136","volume":"103","clinical-trial-number":[{"clinical-trial-number":"nct01599650","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01535261","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Dominika","family":"Podkowinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2197-5838","authenticated-orcid":false,"given":"Wolf-Dieter","family":"Vogl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Gamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Bogunovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca S","family":"Gerendas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Haj Najeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian M","family":"Waldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"2020050713021246000_103.1.36.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(92)31934-7"},{"key":"2020050713021246000_103.1.36.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.02.021"},{"key":"2020050713021246000_103.1.36.3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ophtha.2016.01.011","article-title":"Individualized ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion: twelve-month results of the CRYSTAL study","volume":"123","author":"Larsen","year":"2016","journal-title":"Ophthalmology"},{"key":"2020050713021246000_103.1.36.4","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ophtha.2016.02.030","article-title":"Individualized stabilization criteria\u2013driven ranibizumab versus laser in branch retinal vein occlusion","volume":"123","author":"Tadayoni","year":"2016","journal-title":"Ophthalmology"},{"key":"2020050713021246000_103.1.36.5","first-page":"800","volume-title":"Medical image computing and computer-assisted intervention\u2014MICCAI 2014","volume":"9","author":"Haeker","year":"2014"},{"key":"2020050713021246000_103.1.36.6","first-page":"130","article-title":"Motion artefact correction in retinal optical coherence tomography using local symmetry","volume":"17","author":"Montuoro","year":"2014","journal-title":"Med Image Comput Comput Assist Interv"},{"key":"2020050713021246000_103.1.36.7","doi-asserted-by":"crossref","unstructured":"Vogl WD , Waldstein SM , Gerendas BS , et al . Spatio-temporal signatures to predict retinal disease recurrence. 2015;24:152\u201363.","DOI":"10.1007\/978-3-319-19992-4_12"},{"key":"2020050713021246000_103.1.36.8","doi-asserted-by":"crossref","unstructured":"Terry L , Cassels N , Lu K , et al . Automated retinal layer segmentation using spectral domain optical coherence tomography: evaluation of inter-session repeatability and agreement between devices. PLoS One 2016;11:e0162001.doi:10.1371\/journal.pone.0162001","DOI":"10.1371\/journal.pone.0162001"},{"key":"2020050713021246000_103.1.36.9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ophtha.2016.02.030","article-title":"Individualized stabilization criteria-driven ranibizumab versus laser in branch retinal vein occlusion: six-month results of brighter","volume":"123","author":"Tadayoni","year":"2016","journal-title":"Ophthalmology"},{"key":"2020050713021246000_103.1.36.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90483-9"},{"key":"2020050713021246000_103.1.36.11","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.198937"},{"key":"2020050713021246000_103.1.36.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2008.09.003"},{"key":"2020050713021246000_103.1.36.13","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v2.i6.98"},{"key":"2020050713021246000_103.1.36.14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajo.2015.10.008","article-title":"Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa","volume":"161","author":"Coscas","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"2020050713021246000_103.1.36.15","doi-asserted-by":"crossref","first-page":"OCT486","DOI":"10.1167\/iovs.15-18907","article-title":"Retinal capillary network and foveal avascular zone in eyes with vein occlusion and fellow eyes analyzed with optical coherence tomography angiography","volume":"57","author":"Adhi","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713021246000_103.1.36.16","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000054"},{"key":"2020050713021246000_103.1.36.17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ajo.2014.04.024","article-title":"Paracentral acute middle maculopathy in nonischemic central retinal vein occlusion","volume":"158","author":"Rahimy","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"2020050713021246000_103.1.36.18","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-308813"},{"key":"2020050713021246000_103.1.36.19","unstructured":"Rashid A , Waldstein S , Gerendas B , et al . Reproducibility of retinal thickness measurements across spectral-domain optical coherence tomography devices using Iowa Reference Algorithm. 2016 (accessed 19 Dec 2016)."}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-311614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:56:55Z","timestamp":1601110615000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-311614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12,13]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1136\/bjophthalmol-2017-311614"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311614","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]}}}